ORCID as entered in ROS

Select Publications
2001, 'The ninety-fifth annual general meeting of the association of physicians of Great Britain and Ireland 2001', in QJM an International Journal of Medicine, pp. 643 - 655
,2001, 'IL-1beta and IL-10 genotypes in a high gastric cancer risk province in China', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A743 - A743, http://dx.doi.org/10.1016/S0016-5085(01)83701-X
,2001, 'Pro-inflammatory genotypes of IL-1β, TNF-α and IL-10 increase risk of distal gastric cancer but not of cardia or oesophageal adenocarcinomas', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A86 - A86, http://dx.doi.org/10.1016/S0016-5085(01)80425-X
,2000, 'Mechanisms involved in the development of hypochlorhydria and pangastritis in Helicobacter pylori infection', in Hunt RH; Tytgat GNJ (ed.), HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, SPRINGER, BERMUDA, pp. 373 - 384, presented at 4th Symposium on Helicobacter Pylori - Basic Mechanisms to Clinical Cure, BERMUDA, 26 March 2000 - 29 March 2000, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000167245700039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'H pylori genotypes and clinical and histopathological findings in first degree relatives of patients with non-cardia gastric adenocarcinoma', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A154 - A154
,1999, 'Symptomatic benefit 1-3 years post H-pylori eradication in ulcer patients:: Impact of reflux disease.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A249 - A249
,1998, 'Ablation of fucosyl transferase homologs has varying effects on H-pylori Lewis antigen expression.', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A972 - A972, http://dx.doi.org/10.1016/S0016-5085(98)83958-9
,1998, 'H-pylori induced hypochlorhydria and gastric atrophy associated with increased gastric cancer risk', in JOURNAL OF PATHOLOGY, JOHN WILEY & SONS LTD, pp. 1A - 1A
,1997, 'H-pylori induced hypochlorhydria is associated with increased risk of gastric cancer.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A558 - A558
,1997, 'H-pylori induced hypochlorhydria is associated with increased risk of gastric cancer.', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. WA32 - WA32
,1997, 'H-pylori infection and gastric acid hyposecretion', in JOURNAL OF PATHOLOGY, JOHN WILEY & SONS LTD, pp. A30 - A30
,1997, 'H-pylori-induced hypergastrinaemia is related to bacterial CagA status.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A215 - A215
,1997, 'H-pylori-induced hypergastrinaemia is related to bacterial CagA status.', in GUT, BMJ PUBLISHING GROUP, pp. TH183 - TH183
,1997, 'Hypergastrinaemia is a strong predictor of distal gastric adenocarcinoma among Helicobacter pylori infected persons', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. A45 - A45
,1997, 'Hypergastrinaemia is a strong predictor of distal gastric adenocarcinoma among Helicobacter pylori infected persons', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. A1 - A1
,1997, 'Hypergastrinaemia is a strong predictor of distal gastric adenocarcinoma among Helicobacter pylori infected persons.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A575 - A575
,1997, 'Hypergastrinaemia is a strong predictor of distal gastric adenocarcinoma among Helicobacter pylori infected persons.', in GUT, BMJ PUBLISHING GROUP, pp. TH184 - TH184
,1997, 'Plasma glycine-extended gastrin concentrations and human colorectal cancer.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A638 - A638
,1997, 'Ranitidine treatment induces dyspepsia in previously asymptomatic healthy volunteers.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A293 - A293
,1997, 'Ranitidine treatment induces dyspepsia in previously asymptomatic healthy volunteers.', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. W11 - W11
,1997, 'Regulation of corpus mucosal function in Hp infected DU patients versus healthy volunteers.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A126 - A126
,1997, 'Regulation of corpus mucosal function in HP infected DU patients versus healthy volunteers.', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. W12 - W12
,1997, 'Variable symptomatic response to H-pylori eradication in ulcer patients.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A215 - A215
,1996, 'Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer', in Scandinavian Journal of Gastroenterology Supplement, pp. 32 - 37
,1996, 'Divergent effects of H-pylori on acid secretion.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A102 - A102
,1996, 'Evidence supporting a H-pylori test and treat strategy for simple dyspepsia.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A28 - A28
,1996, 'Parietal cell sensitivity to gastrin distinguishes H-pylori infected DU patients from infected healthy volunteers', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A116 - A116
,1995, 'GASTRIN AND ITS PRECURSORS IN HUMAN COLORECTAL-CANCER', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A524 - A524
,1994, 'A SUBSTANTIAL PROPORTION OF NUD PATIENTS HAVE THE SAME ABNORMALITY OF ACID-SECRETION AS DU PATIENTS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A74 - A74
,1994, 'FASTING AND MEAL-STIMULATED GASTRIN-LEVELS PREOPERATIVELY AND POSTOPERATIVELY IN COLORECTAL TUMOR PATIENTS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A428 - A428
,1994, 'HELICOBACTER-PYLORI IMPAIRS THE INHIBITORY CONTROL OF ACID-SECRETION IN DUODENAL-ULCER PATIENTS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A74 - A74
,1994, 'MARKED REBOUND ACID HYPERSECRETION IN HEALTHY-VOLUNTEERS FOLLOWING RANITIDINE', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A74 - A74
,1994, 'SUCRALFATE SUPPRESSES HELICOBACTER-PYLORI INFECTION AND REDUCES GASTRIC-ACID SECRETION BY 50-PERCENT IN DU PATIENTS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A45 - A45
,1993, 'ERADICATING HELICOBACTER-PYLORI LOWERS GASTRIN-MEDIATED ACID-SECRETION BY 70-PERCENT IN DU PATIENTS AND BY 50-PERCENT IN HEALTHY-VOLUNTEERS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A75 - A75
,1993, 'OMEPRAZOLE INHIBITS AZOXYMETHANE-INDUCED COLORECTAL CARCINOGENESIS IN RATS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A441 - A441
,1992, 'ERADICATION OF HELICOBACTER-PYLORI INFECTION DURING LONG-TERM SULFASALAZINE THERAPY', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. S28 - S28
,1992, 'ERADICATION OF HELICOBACTER-PYLORI LOWERS GASTRIN-MEDIATED ACID-SECRETION BY 70-PERCENT IN DU PATIENTS', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. S28 - S28
,1987, 'SEPARATE SIGNALS ARE REQUIRED FOR THE STIMULATION OF HEPATIC SYNTHESIS OF THE 3RD AND 4TH COMPONENTS OF COMPLEMENT DURING THE ACUTE-PHASE RESPONSE', in JOURNAL OF PATHOLOGY, JOHN WILEY & SONS LTD, pp. A68 - A68
,1986, 'EFFECTS OF RIFAMPICIN ON HEME-BIOSYNTHESIS AND HEPATIC MONOOXYGENASE ACTIVITY IN HEALTHY-SUBJECTS', in BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, BLACKWELL SCIENCE LTD, pp. P602 - P602
,1985, 'NEW OBSERVATIONS IN GILBERTS SYNDROME', in SCOTTISH MEDICAL JOURNAL, HERMISTON PUBLICATIONS LTD, pp. 56 - 57
,2022, 'Characterization of gut microbiota and exploration of potential predictive model for hepatocellular carcinoma microvascular invasion', ENGLAND, London, Vol. 77, pp. S920 - S921, presented at International Liver Congress, ENGLAND, London, 22 June 2022 - 26 June 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000826275104366&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'The MothersBabies Study: analysing the preconception microbiome to determine risk of adverse maternal-child health outcomes', presented at Brighter Beginnings First 2000 Days Summit, NSW Ministry of Health, 31 October 2022 - 01 November 2022, https://willorganise.eventsair.com/bb-first-2000-days-summit/day-2
,2023, 'Re-purposing non-oncology agent itraconazole to target the dynamic cellular ecosystem of pancreatic cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, Vol. 84, presented at AACR Special Conference - Pancreatic Cancer, MA, Boston, 27 September 2023 - 30 September 2023, http://dx.doi.org/10.1158/1538-7445.PANCA2023-A029
,2023, 'The anti-fungal itraconazole improves immunotherapy efficacy in pancreatic ductal adenocarcinoma by reversing the immune-suppressive tumor microenvironment', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, Vol. 84, presented at AACR Special Conference - Pancreatic Cancer, MA, Boston, 27 September 2023 - 30 September 2023, http://dx.doi.org/10.1158/1538-7445.PANCA2023-C017
,2022, 'EFFECT OF GUT INFLUENCE ON THE IMMUNE ENVIRONMENT IN PRE-CLINICAL HCC', in GUT, BMJ PUBLISHING GROUP, Vol. 71, pp. A5 - A5, http://dx.doi.org/10.1136/gutjnl-2022-IDDF.6
,2022, 'Effect of gut influence on the immune environment in preclinical hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 37, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852585700071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Characterization analysis of gut and bile microbiota for cholangiocarcinomas.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 40, pp. e16150 - e16150, http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e16150
,2022, 'Characterization analysis of gut and bile microbiota for cholangiocarcinomas.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 40, pp. E16150 - E16150, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000863680303224&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'THE ROLE OF THE MICROBIOME AND METABOLIC SYNDROME IN SCHIZOPHRENIA AND EARLY PSYCHOSIS', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, Vol. 56, pp. 189 - 189, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000792769900448&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, '880: THE SHORT-TERM AND LONG-TERM IMPACTS OF H. PYLORI ERADICATION ON THE ANTIBIOTIC RESISTANCE AND RESISTOME OF GUT MICROBIOTA- A MULTICENTER RANDOMIZED TRIAL', in Gastroenterology, Elsevier BV, Vol. 162, pp. S - 212, http://dx.doi.org/10.1016/s0016-5085(22)60509-2
,